Regeneron News and Research

RSS
One-two punch of powerful antibodies may be best way to stop Ebola virus

One-two punch of powerful antibodies may be best way to stop Ebola virus

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix resubmits NDA for DEXTENZA

New tool determines best treatment plan for adults with severe asthma

New tool determines best treatment plan for adults with severe asthma

Regeneron collaborates with Zoetis to research antibody therapies for animals

Regeneron collaborates with Zoetis to research antibody therapies for animals

Novel PET imaging shows promise for noninvasively detecting inflammation in people with IBD

Novel PET imaging shows promise for noninvasively detecting inflammation in people with IBD

Clinical trial begins enrollment to test safety of experimental MERS treatments

Clinical trial begins enrollment to test safety of experimental MERS treatments

PCSK9 inhibitor reduces cardiovascular events in ACS patients with high cholesterol

PCSK9 inhibitor reduces cardiovascular events in ACS patients with high cholesterol

Oncolytic virus alerts the immune system to attack tumors

Oncolytic virus alerts the immune system to attack tumors

Discovery opens new doors to developing vaccines for preventing staph skin infections

Discovery opens new doors to developing vaccines for preventing staph skin infections

Regeneron forms consortium to accelerate largest widely-available human sequencing resource

Regeneron forms consortium to accelerate largest widely-available human sequencing resource

Evolution of immuno-oncology

Evolution of immuno-oncology

NovaSeq, the new sequencer by Illumina, said to transform the field of genomics

NovaSeq, the new sequencer by Illumina, said to transform the field of genomics

Scientists use unified analysis approach for diagnosing diseases with multiple genetic causes

Scientists use unified analysis approach for diagnosing diseases with multiple genetic causes

Sostdc1 gene may play vital role in fracture healing process

Sostdc1 gene may play vital role in fracture healing process

New study aims to identify biomarkers linked to cartilage degradation in OA patients

New study aims to identify biomarkers linked to cartilage degradation in OA patients

Phase 3 study: Sarilumab monotherapy meets primary endpoint in active rheumatoid arthritis patients

Phase 3 study: Sarilumab monotherapy meets primary endpoint in active rheumatoid arthritis patients

Regeneron, Sanofi to jointly advance new immuno-oncology treatment options for cancer patients

Regeneron, Sanofi to jointly advance new immuno-oncology treatment options for cancer patients

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

EMA's CHMP recommends approval of Praluent (alirocumab) for use in patients with hypercholesterolemia

EMA's CHMP recommends approval of Praluent (alirocumab) for use in patients with hypercholesterolemia

Phase 3 ODYSSEY JAPAN trial of Praluent injection meets primary endpoint

Phase 3 ODYSSEY JAPAN trial of Praluent injection meets primary endpoint